Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)
6.62
0.00 (0.00%)
Apr 29, 2026, 3:04 PM CST
SHE:002370 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 586.46 | 618.72 | 743.85 | 720.47 | 757.62 | 821.11 |
Cash & Short-Term Investments | 616.52 | 618.72 | 743.85 | 720.47 | 757.62 | 821.11 |
Cash Growth | -20.63% | -16.82% | 3.25% | -4.90% | -7.73% | -9.06% |
Accounts Receivable | 125.52 | 155.05 | 111.68 | 111.8 | 115.65 | 85.24 |
Other Receivables | 0.61 | 0.53 | 26.4 | 29.19 | 15.14 | 1.18 |
Receivables | 126.13 | 155.58 | 138.08 | 140.99 | 130.79 | 86.42 |
Inventory | 100.94 | 107.25 | 70.13 | 89.47 | 95.2 | 60.9 |
Other Current Assets | 14.47 | 16.72 | 3.1 | 4.24 | 21.23 | 27.41 |
Total Current Assets | 858.06 | 898.27 | 955.16 | 955.18 | 1,005 | 995.85 |
Property, Plant & Equipment | 290.36 | 294.73 | 338.11 | 364.79 | 385.89 | 433.99 |
Long-Term Investments | 36.31 | 38.01 | 38.49 | 37.75 | 40.96 | 58.27 |
Other Intangible Assets | 42.71 | 44 | 54.2 | 59.21 | 57.22 | 51.57 |
Long-Term Deferred Tax Assets | - | - | - | - | 0.25 | - |
Long-Term Deferred Charges | 5.45 | 4.7 | 15.82 | 11.37 | 22.14 | 71.1 |
Other Long-Term Assets | - | - | - | 1.08 | 12.56 | - |
Total Assets | 1,233 | 1,280 | 1,402 | 1,429 | 1,524 | 1,611 |
Accounts Payable | 76.84 | 103.97 | 45.77 | 51.8 | 89.83 | 53.93 |
Accrued Expenses | 6.19 | 13.13 | 17.08 | 16.98 | 22.73 | 21.65 |
Short-Term Debt | - | - | 30.06 | 50.06 | 50.06 | - |
Current Portion of Long-Term Debt | - | - | 301.7 | - | - | 110.16 |
Current Portion of Leases | - | - | - | - | 1.7 | 1.35 |
Current Income Taxes Payable | 1.63 | 5.15 | - | - | - | - |
Current Unearned Revenue | 14.16 | 14.75 | 2.23 | 7.96 | 14.47 | 2.77 |
Other Current Liabilities | 9.71 | 15.24 | 19.6 | 35.01 | 43.58 | 24.3 |
Total Current Liabilities | 108.53 | 152.24 | 416.44 | 161.8 | 222.38 | 214.15 |
Long-Term Debt | - | - | - | 639.48 | 900.01 | 861.58 |
Long-Term Leases | - | - | - | - | - | 1.34 |
Long-Term Unearned Revenue | 2.93 | 3.21 | 4.36 | 5.56 | 6.83 | 15.16 |
Long-Term Deferred Tax Liabilities | 3.73 | 3.98 | 3.86 | 3.61 | 3.55 | 5.94 |
Other Long-Term Liabilities | - | - | 4.93 | 38.04 | 89.83 | 79.65 |
Total Liabilities | 115.18 | 159.43 | 429.59 | 848.5 | 1,223 | 1,178 |
Common Stock | 745.67 | 745.67 | 728.59 | 609.17 | 536.69 | 536.62 |
Additional Paid-In Capital | 2,005 | 2,005 | 1,907 | 1,594 | 1,310 | 1,309 |
Retained Earnings | -1,633 | -1,630 | -1,727 | -1,761 | -1,749 | -1,616 |
Comprehensive Income & Other | - | - | 63.35 | 138.8 | 203.57 | 203.8 |
Total Common Equity | 1,118 | 1,120 | 972.18 | 580.87 | 301.27 | 432.96 |
Shareholders' Equity | 1,118 | 1,120 | 972.18 | 580.87 | 301.27 | 432.96 |
Total Liabilities & Equity | 1,233 | 1,280 | 1,402 | 1,429 | 1,524 | 1,611 |
Total Debt | - | - | 331.75 | 689.54 | 951.78 | 974.43 |
Net Cash (Debt) | 616.52 | 618.72 | 412.1 | 30.94 | -194.16 | -153.31 |
Net Cash Growth | 29.44% | 50.14% | 1232.00% | - | - | - |
Net Cash Per Share | 0.83 | 0.84 | 0.60 | 0.05 | -0.37 | -0.29 |
Filing Date Shares Outstanding | 739.29 | 742.56 | 728.59 | 609.17 | 536.69 | 536.62 |
Total Common Shares Outstanding | 739.29 | 742.56 | 728.59 | 609.17 | 536.69 | 536.62 |
Working Capital | 749.53 | 746.04 | 538.72 | 793.38 | 782.46 | 781.7 |
Book Value Per Share | 1.51 | 1.51 | 1.25 | 0.72 | 0.18 | 0.81 |
Tangible Book Value | 1,075 | 1,076 | 917.99 | 521.67 | 244.04 | 381.39 |
Tangible Book Value Per Share | 1.45 | 1.45 | 1.17 | 0.63 | 0.07 | 0.71 |
Buildings | - | - | 429.39 | 427.32 | 413.92 | 426.8 |
Machinery | - | - | 224.35 | 221.97 | 220.86 | 221.01 |
Construction In Progress | - | - | 0.03 | 0.03 | - | 0.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.